Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ACT075
MIFTS: 57

Acute Myocardial Infarction

Categories: Blood diseases, Cardiovascular diseases, Genetic diseases, Oral diseases, Respiratory diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Acute Myocardial Infarction

About this section

MalaCards integrated aliases for Acute Myocardial Infarction:

Name: Acute Myocardial Infarction 39 12 56 15 17 74

Classifications:

MalaCards categories:
Global: Genetic diseases
Anatomical: Cardiovascular diseases Respiratory diseases Oral diseases Blood diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:9408
ICD9CM 36 410 410.9 410.90
NCIt 51 C35204
SNOMED-CT 69 57054005
ICD10 34 I21 I21.9
UMLS 74 C0155626
Sources

Summaries for Acute Myocardial Infarction

About this section
MalaCards based summary : Acute Myocardial Infarction is related to cardiac rupture and acute anterolateral myocardial infarction, and has symptoms including angina pectoris and chest pain. An important gene associated with Acute Myocardial Infarction is MIR208B (MicroRNA 208b), and among its related pathways/superpathways is A-beta Pathways: Plaque Formation and APP Metabolism. The drugs Dopamine and Metoclopramide have been mentioned in the context of this disorder. Affiliated tissues include heart, bone and kidney, and related phenotype is cardiovascular system.

Sources

Related Diseases for Acute Myocardial Infarction

About this section

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction

Diseases related to Acute Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 514)
# Related Disease Score Top Affiliating Genes
1 cardiac rupture 33.2 CRP PLAT
2 acute anterolateral myocardial infarction 32.8 ACE PIK3C2A
3 cardiogenic shock 32.5 NPPB PIK3C2A PLAT
4 myocardial infarction 32.2 ACE ADRB1 CDKN2B-AS1 CRP F3 FABP3
5 angina pectoris 32.0 ACE CRP NPPB PIK3C2A PLAT
6 thrombosis 31.8 F3 PLAT SELP
7 left bundle branch hemiblock 31.8 ACE NPPB TNNI3
8 ischemia 31.7 ACE MB PLAT SELP
9 myocarditis 31.6 MB NPPB TNNI3
10 atrial standstill 1 31.6 ACE ADRB1 NPPB TNNI3
11 cardiac arrest 31.5 ACE NPPB PIK3C2A
12 atrial fibrillation 31.4 ACE ADRB1 CRP NPPB PLAT SELP
13 coronary stenosis 31.4 ACE CRP NPPB PIK3C2A TNNI3
14 ischemic heart disease 31.4 ACE CRP NPPB
15 antiphospholipid syndrome 31.4 F3 PLAT SELP
16 pericardial effusion 31.4 CRP NPPB PIK3C2A
17 arteries, anomalies of 31.3 ACE CRP F3 MB NPPB PLAT
18 endocarditis 31.3 CRP PIK3C2A PLAT TNNI3
19 pulmonary edema 31.2 ACE CRP NPPB PIK3C2A
20 thrombocytosis 31.0 CRP F3 SELP
21 coronary artery anomaly 31.0 ACE ADRB1 CRP FABP3 MB NPPB
22 disseminated intravascular coagulation 30.9 F3 MB PIK3C2A PLAT
23 peripheral vascular disease 30.9 ACE CRP F3 PLAT SELP
24 pulmonary embolism 30.9 CRP F3 FABP3 NPPB PLAT TNNI3
25 sleep apnea 30.9 ACE CRP NPPB
26 heart disease 30.8 ACE ADRB1 CRP F3 FABP3 NPPB
27 aortic valve disease 1 30.8 ACE CRP NPPB TNNI3
28 systolic heart failure 30.8 ACE ADRB1 CRP NPPB
29 congestive heart failure 30.7 ACE ADRB1 CDKN2B-AS1 MHRT NPPB
30 cerebrovascular disease 30.7 ACE CRP PLAT SELP
31 respiratory failure 30.7 ACE CRP F3 PIK3C2A
32 stroke, ischemic 30.7 ACE CDKN2B-AS1 CRP F3 PLAT SELP
33 vascular disease 30.7 ACE CRP F3 PLAT SELP
34 platelet aggregation, spontaneous 30.6 PLAT SELP
35 arteriosclerosis 30.6 ACE CRP F3 SELP
36 coronary heart disease 1 30.5 ACE ADRB1 CDKN2B-AS1 CRP NPPB PLAT
37 aortic valve disease 2 30.4 ACE CRP NPPB
38 toxic myocarditis 30.4 NPPB PIK3C2A TNNI3
39 gas gangrene 30.4 MB PIK3C2A TNNI3
40 systemic scleroderma 30.4 ACE CRP SELP
41 chagas disease 30.3 ACE ADRB1 NPPB
42 marantic endocarditis 30.1 F3 PLAT
43 dilated cardiomyopathy 30.1 ACE ADRB1 CRP FABP3 MB MIR499A
44 intermediate coronary syndrome 30.0 ACE CRP F3 MB PIK3C2A PLAT
45 peripheral artery disease 29.9 ACE CDKN2B-AS1 CRP SELP
46 diabetes mellitus, noninsulin-dependent 29.7 ACE CDKN2B-AS1 CRP MIR29A PLAT
47 subendocardial infarction acute myocardial infarction 12.4
48 strictly posterior acute myocardial infarction 12.4
49 coronary artery disease, autosomal dominant, 1 11.5
50 acute inferoposterior infarction 11.4

Comorbidity relations with Acute Myocardial Infarction via Phenotypic Disease Network (PDN): (show all 22)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Aortic Valve Disease 1
Cardiac Arrest Chronic Kidney Failure
Chronic Myocardial Ischemia Decubitus Ulcer
Deficiency Anemia Familial Atrial Fibrillation
Generalized Atherosclerosis Heart Disease
Hypertension, Essential Intermediate Coronary Syndrome
Ischemic Heart Disease Kidney Disease
Mitral Valve Disease Peripheral Vascular Disease
Protein-Energy Malnutrition Respiratory Failure
Schizophreniform Disorder Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Acute Myocardial Infarction:



Diseases related to Acute Myocardial Infarction
Sources

Symptoms & Phenotypes for Acute Myocardial Infarction

About this section

UMLS symptoms related to Acute Myocardial Infarction:


angina pectoris, chest pain

MGI Mouse Phenotypes related to Acute Myocardial Infarction:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.32 ACE ADRB1 CRP F3 FABP3 MB
Sources

Drugs & Therapeutics for Acute Myocardial Infarction

About this section

Drugs for Acute Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 592)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2,Phase 3,Not Applicable 62-31-7, 51-61-6 681
2
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
3
Morphine Approved, Investigational Phase 4,Phase 3,Not Applicable 57-27-2 5288826
4
Ticagrelor Approved Phase 4,Phase 2,Phase 3,Not Applicable 274693-27-5 9871419
5
Pravastatin Approved Phase 4 81093-37-0 54687
6
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
7
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53123-88-9 46835353 5284616 6436030
8
Abciximab Approved Phase 4,Phase 3,Phase 2,Not Applicable 143653-53-6
9
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 159351-69-6 70789204 6442177
10
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable 120202-66-6, 113665-84-2 60606
11
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-78-2 2244
12
Thrombin Approved, Investigational Phase 4,Phase 3
13
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
14
Bivalirudin Approved, Investigational Phase 4,Phase 3,Not Applicable 128270-60-0 16129704
15
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
16
Tirofiban Approved Phase 4,Phase 3,Not Applicable 144494-65-5 60947
17
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 2833 6167
18
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 46507594 772
19
Nicorandil Approved, Investigational Phase 4,Phase 3,Not Applicable 65141-46-0 47528
20
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
21
Desflurane Approved Phase 4 57041-67-5 42113
22
Metformin Approved Phase 4,Phase 2,Phase 3 657-24-9 14219 4091
23
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7440-66-6 32051
24
Insulin glargine Approved Phase 4,Phase 3,Not Applicable 160337-95-1
25
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 33069-62-4 36314
26
Pantoprazole Approved Phase 4 102625-70-7 4679
27
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
28
Glimepiride Approved Phase 4,Phase 3 93479-97-1 3476
29
Pioglitazone Approved, Investigational Phase 4,Phase 3 111025-46-8 4829
30
Gliclazide Approved Phase 4,Phase 3 21187-98-4 3475
31
Glyburide Approved Phase 4,Phase 3 10238-21-8 3488
32
Apixaban Approved Phase 4,Phase 3 503612-47-3 10182969
33
Rivaroxaban Approved Phase 4,Phase 3 366789-02-8
34
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198
35
Valsartan Approved, Investigational Phase 4,Phase 3,Not Applicable 137862-53-4 60846
36
Dalteparin Approved Phase 4,Phase 3,Not Applicable 9005-49-6
37
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
38
Cefuroxime Approved Phase 4 55268-75-2 5479529 5361202
39
Metronidazole Approved Phase 4,Not Applicable 443-48-1 4173
40
Atorvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 134523-00-5 60823
41 Nutmeg Approved Phase 4,Phase 3
42
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 37350-58-6, 51384-51-1 4171
43
Lenograstim Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 135968-09-1
44
Sargramostim Approved, Investigational Phase 4,Phase 2,Phase 3 123774-72-1, 83869-56-1
45
Simvastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable 79902-63-9 54454
46
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 58-61-7 60961
47
Chromium Approved Phase 4,Phase 3,Phase 2,Not Applicable 7440-47-3 27668
48
Furosemide Approved, Vet_approved Phase 4,Phase 3 54-31-9 3440
49
Amiodarone Approved, Investigational Phase 4,Not Applicable 1951-25-3 2157
50
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162

Interventional clinical trials:

(show top 50) (show all 1364)
# Name Status NCT ID Phase Drugs
1 Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction Unknown status NCT02627950 Phase 4 Morphinhydrochloricum;Metoclopramide;Ticagrelor;Isotonic sodium chloride
2 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
3 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
4 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
5 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4 Erythropoietin
6 Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction Unknown status NCT02524964 Phase 4 sodium tanshinone IIA sulfonate
7 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
8 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
9 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4 Tirofiban
10 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
11 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4 Colchicine
12 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4 Colchicine 2 mg loading dose; 0.5 mg bid for 5 days;Placebo
13 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
14 Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography Unknown status NCT01875835 Phase 4
15 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
16 P3AMI Antiplatelet Trial Unknown status NCT02376283 Phase 4 Prasugrel;Clopidogrel;ticagrelor
17 The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients Unknown status NCT02850627 Phase 4 Tongguan capsule;placebo capsule
18 Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI) Unknown status NCT01115842 Phase 4 Vitamin D
19 Treatment of Reperfusion Event by Vitamin C Infusion Unknown status NCT01090895 Phase 4 Vitamin C;Placebo
20 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
21 Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Unknown status NCT02446730 Phase 4 Prasugel;Clopidogrel
22 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
23 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
24 Desflurane-induced Myocardial Protection Unknown status NCT02019797 Phase 4 Desflurane
25 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4 Ticagrelor;Clopidogrel
26 Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) Unknown status NCT01035528 Phase 4 insulin glargine;metformin
27 Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI Unknown status NCT02792712 Phase 4 Ticagrelor;Clopidogrel
28 CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS Unknown status NCT00933400 Phase 4
29 Multifactorial Intervention in Type 2 Diabetes - Italy Unknown status NCT01240070 Phase 4
30 Xience/Promus for Long Coronary Lesion Registry Unknown status NCT01147237 Phase 4
31 Treatment of Coronary In-Stent Restenosis Unknown status NCT01735825 Phase 4
32 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
33 Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial Unknown status NCT00700856 Phase 4 add-on pioglitazone;add-on sulphonylurea
34 Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Unknown status NCT02666157 Phase 4 Dabigatran etexilate;Rivaroxaban;Apixaban
35 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
36 The Pacing vs No Pacing Study - PNP Study Unknown status NCT02498639 Phase 4
37 The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI Unknown status NCT02658838 Phase 4 Ticagrelor;full amount low molecular weight heparin;half amount low molecular weight heparin;No low molecular weight heparin
38 Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis Unknown status NCT02505581 Phase 4 Extra dosage - cefuroxime (750mg) I.V;Cefuroxime 750mg oral;Metronidazole 250mg oral;Metronidazole 1,5gr Intravenous;Cefuroxime 1g Intravenous
39 Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction Completed NCT02291796 Phase 4 Bezafibrate
40 Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction Completed NCT00302419 Phase 4 intracoronary infusion,
41 GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction Completed NCT00538317 Phase 4 tirofiban;tirofiban
42 REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction Completed NCT01381185 Phase 4 Aspirin 200mg qd, Clopidogrel 2x75mg qd
43 Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction Completed NCT00863629 Phase 4 Insulin
44 The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction Completed NCT00882466 Phase 4 human recombinant erythropoietin
45 BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial. Completed NCT01696110 Phase 4 Bivalirudin;heparin;heparin plus tirofiban
46 Southwest German Interventional Study in Acute Myocardial Infarction III Completed NCT01124890 Phase 4
47 Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction Completed NCT00712894 Phase 4 Diltiazem;Verapamil;Nitroglycerin
48 Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction Completed NCT00882739 Phase 4 Clopidogrel 300 mg;Clopidogrel 600 mg;Clopidogrel 900 mg
49 Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction Completed NCT00627809 Phase 4 Streptokinase
50 Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction Completed NCT00536887 Phase 4 atorvastatin

Search NIH Clinical Center for Acute Myocardial Infarction

Sources

Genetic Tests for Acute Myocardial Infarction

About this section
Sources

Anatomical Context for Acute Myocardial Infarction

About this section

MalaCards organs/tissues related to Acute Myocardial Infarction:

42
Heart, Bone, Kidney, Bone Marrow, Endothelial, Testes, Brain
Sources

Publications for Acute Myocardial Infarction

About this section

Articles related to Acute Myocardial Infarction:

(show top 50) (show all 7024)
# Title Authors Year
1
In Reply-Acute Myocardial Infarction During Pregnancy and the Puerperium: Experiences and Challenges From Southern India. ( 31054614 )
2019
2
Association Between Medication Adherence and 1-Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China. ( 31057004 )
2019
3
Serum potassium levels and mortality of patients with acute myocardial infarction: A systematic review and meta-analysis of cohort studies. ( 31060369 )
2019
4
Dysrhythmias and heart failure complicating acute myocardial infarction: An emergency medicine review. ( 31060863 )
2019
5
Functional suppression of Epiregulin impairs angiogenesis and aggravates left ventricular remodeling by disrupting the extracellular-signal-regulated kinase1/2 signaling pathway in rats after acute myocardial infarction. ( 31062344 )
2019
6
Lambda-like J wave due to acute myocardial infarction of the diagonal branch. ( 31064936 )
2019
7
PTEN gene & TNF-alpha in acute myocardial infarction. ( 31065586 )
2019
8
Altered nutritional status, inflammation and systemic vulnerability in patients with acute myocardial infarction undergoing percutaneous coronary revascularisation: A prospective study in a level 3 cardiac critical care unit. ( 31066157 )
2019
9
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? ( 31066332 )
2019
10
Selenium deficiency and the dynamics of changes of thyroid profile in patients with acute myocardial infarction and chronic heart failure. ( 31066725 )
2019
11
Hospital-Specific Mortality for Acute Myocardial Infarction Versus Emergency Percutaneous Coronary Intervention in New York State. ( 31072516 )
2019
12
Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction. ( 31072581 )
2019
13
Cardiogenic Shock in Takotsubo Cardiomyopathy Versus Acute Myocardial Infarction: An 8-Year National Perspective on Clinical Characteristics, Management, and Outcomes. ( 31078481 )
2019
14
Resorbable Magnesium Scaffolds in Acute Myocardial Infarction Patients: "To Be or Not to Be"? ( 31079091 )
2019
15
Sirolimus-Eluting Magnesium Resorbable Scaffold Implantation in Patients with Acute Myocardial Infarction. ( 31079093 )
2019
16
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial. ( 31081342 )
2019
17
Effect of Bruton's tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction. ( 31082751 )
2019
18
Revascularization strategies in cardiogenic shock after acute myocardial infarction. ( 31082824 )
2019
19
Combined intracoronary assessment and treatment of a patient with coronary plaque rapid progression prior to acute myocardial infarction: A case report. ( 31083259 )
2019
20
Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction. ( 31085502 )
2019
21
Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention. ( 31086513 )
2019
22
Expression of miRNA-214 in the sera of elderly patients with acute myocardial infarction and its effect on cardiomyocyte apoptosis. ( 31086597 )
2019
23
The Associations between Meat Group Consumption and Acute Myocardial Infarction Risks in an Iranian Population: a Case-Control Study. ( 31089469 )
2019
24
Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis". ( 31090240 )
2019
25
Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardiovasc Interv. 2018 Dec 28. [epub ahead of print]). ( 31090250 )
2019
26
Cardiogenic Shock Following Acute Myocardial Infarction: What's New? ( 31090679 )
2019
27
Thirty-Day Hospital Readmission After Acute Myocardial Infarction in China. ( 31092023 )
2019
28
Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction. ( 31092195 )
2019
29
DEFINE-ing the next steps in interventional cardiology: updates on coronary physiology, acute myocardial infarction, and dual-antiplatelet therapy from American College of Cardiology 2019. ( 31093653 )
2019
30
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned GPI during primary percutaneous coronary intervention in acute myocardial infarction - a VALIDATE-SWEDEHEART substudy. ( 31093662 )
2019
31
Are Their Young Coronaries Old Enough? Angiographic Findings In Young Patients With Acute Myocardial Infarction. ( 31094106 )
2019
32
Unplanned Readmissions After Acute Myocardial Infarction: 1-Year Trajectory Following Discharge From a Safety Net Hospital. ( 31094732 )
2019
33
Measuring of quality of care in patients with stroke and acute myocardial infarction: An application of algebra effectiveness model. ( 31096434 )
2019
34
Comparison of Patients with Acute Myocardial Infarction According to Age. ( 31097855 )
2019
35
Influence of Local Myocardial Infarction on Endothelial Function, Neointimal Progression, and Inflammation in Target and Non-Target Vascular Territories in a Porcine Model of Acute Myocardial Infarction. ( 31099195 )
2019
36
The curious case of acute myocardial infarction due to paradoxical embolism in young man with ASD II. ( 31099759 )
2019
37
Microeconomic Costs, Insurance, and Catastrophic Health Spending Among Patients With Acute Myocardial Infarction in India: Substudy of a Randomized Clinical Trial. ( 31099866 )
2019
38
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry. ( 31106384 )
2019
39
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels. ( 30894407 )
2019
40
Computerized Tomography is an Effective Modality to Evaluate Iatrogenic Aortocoronary Dissection with Acute Myocardial Infarction. ( 30895759 )
2019
41
Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3 h. ( 30896787 )
2019
42
Testosterone deficiency reduces the effects of late cardiac remodeling after acute myocardial infarction in rats. ( 30897106 )
2019
43
Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy. ( 30902531 )
2019
44
In-hospital Takotsubo syndrome versus in-hospital acute myocardial infarction among patients admitted for non-cardiac diseases: a nationwide inpatient database study. ( 30903314 )
2019
45
Clinical case of successful management of acute myocardial infarction during pregnancy. ( 30903792 )
2019
46
Missed Acute Myocardial Infarction (MAMI) in a rural and regional setting. ( 30906847 )
2019
47
Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis. ( 30909587 )
2019
48
Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study. ( 30909774 )
2019
49
Acute myocardial infarction in pregnancy: spasm caused by hyperthyroidism? ( 30909844 )
2019
50
Association of in-hospital resource utilization with post-acute spending in Medicare beneficiaries hospitalized for acute myocardial infarction: a cross-sectional study. ( 30909904 )
2019
Sources

Variations for Acute Myocardial Infarction

About this section

Copy number variations for Acute Myocardial Infarction from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 210497 6 30400000 36600000 Amplification C4B Acute myocardial infarction
Sources

Expression for Acute Myocardial Infarction

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Acute Myocardial Infarction patients vs. healthy controls: 35
# Gene Description Tissue Up/Dn Fold Change (log2) P value
1 EGR3 early growth response 3 Blood + 5.52 0.000
2 LOC286058 uncharacterized LOC286058 Blood + 4.73 0.000
3 CXCL8 chemokine (C-X-C motif) ligand 8 Blood + 3.51 0.004
4 LEP leptin Heart + 3.45 0.011
5 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein Blood + 3.18 0.007
Search GEO for disease gene expression data for Acute Myocardial Infarction.
Sources

Pathways for Acute Myocardial Infarction

About this section

Pathways related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
A-beta Pathways: Plaque Formation and APP Metabolism 66
9.98 ACE PLAT
Sources

GO Terms for Acute Myocardial Infarction

About this section

Cellular components related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.23 ACE CRP F3 FABP3 MIR29A NPPB

Biological processes related to Acute Myocardial Infarction according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of vascular endothelial cell proliferation GO:1905564 9.26 MIR29A MIR499A
2 heart contraction GO:0060047 9.16 ACE TNNI3
3 regulation of blood vessel diameter GO:0097746 8.96 ACE NPPB
4 transition between fast and slow fiber GO:0014883 8.62 MIR208B MIR499A
Sources

Sources for Acute Myocardial Infarction

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....